Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings

Skin and soft tissue infections (SSTIs) make up approximately 3% to 10% of inpatient hospital admissions in the US (1,2), with inpatient costs being the largest cost component of their overall management (3). In approximately 40% of patients who present to US emergency departments (EDs) with SSTIs, the sole reason for their admission is administration of an intravenous (IV) antibiotic (4). Various approaches have been pursued to avoid the need for hospitalization based solely on antibiotic administration needs by helping shift treatment to the outpatient setting (5).

Source: The Journal of Emergency Medicine - March 11, 2024 Category: Emergency Medicine Authors: Frank LoVecchio, Matthew W. McCarthy, Xiaolan Ye, Alasdair D. Henry, Quan V. Doan, John L. Lock, Todd Riccobene, Rosie D. Lyles, David A. Talan Tags: Pharmacology in Emergency Medicine Source Type: research